Models to understand the population-level impact of mixed strain M. tuberculosis infections

Journal of Theoretical Biology

Volumn 280, Issue 1, 2011, Pages 88-100

  Sergeev, Rinat ^a,b   Colijn, Caroline ^c   Cohen, Ted ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b IOFFE INSTITUTE   (Russian Federation)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibiotic resistance; Coinfection; Epidemiology; Mathematical model; Mycobacterium

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIUM; COMPETITION (ECOLOGY); DISEASE TREATMENT; ECOLOGICAL MODELING; EPIDEMIOLOGY; HOST-PATHOGEN INTERACTION; IMMUNOCOMPETENCE; INFECTIOUS DISEASE; MUTATION; POPULATION ECOLOGY; TUBERCULOSIS;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DRUG RESISTANT TUBERCULOSIS; HOST PATHOGEN INTERACTION; HUMAN; INTRASPECIFIC COMPETITION; MATHEMATICAL MODEL; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STEADY STATE; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MODELS, THEORETICAL; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 79955486696     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2011.04.011     Document Type: Article

References (52)

1. Alavez-Ramirez J.A., Castellanos J.R.A., Esteva L., Flores J.A., Fuentes-Allen J.L., Garcia-Ramos G., Gomez G., Lopez-Estrada J. Within-host population dynamics of antibiotic-resistant M. tuberculosis. Mathematical Medicine and Biology 2007, 24:35-56.
2. Antia R., Regoes R.R., Koella J.C., Bergstrom C.T. The role of evolution in the emergence of infectious diseases. Nature 2003, 426:658-661.
3. Armstrong R.A., McGehe R. Competitive exclusion. The American Naturalist 1980, 115:151-170.
4. Baldeviano-Vidalon G.C., Quispe-Torres N., Bonilla-Asalde C., Gastiaburu-Rodriguez D., Pro-Cuba J.E., Llanos-Zavalaga F. Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. International Journal of Tuberculosis and Lung Disease 2005, 9:1155-1160.
5. Billington O.J., McHugh T.D., Gillespie S.H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999, 43:1866-1869.
6. Bjorkman J., Nagaev I., Berg O.G., Hughes D., Andersson D.I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000, 287:1479-1482.
7. Blower S.M., Small P.M., Hopewell P.C. Control strategies for tuberculosis epidemics: new models for old problems. Science 1996, 273:497-500.
8. Bottger E.C., Springer B., Pletschette M., Sander P. Fitness of antibioticresistant microorganisms and compensatory mutations. Nature Medicine 1998, 4:1343-1344.
9. Caminero J.A., Pena M.J., Campos-Herrero M.I., Rodriguez J.C., Afonso O., Martin C., Pavon J.M., Torres M.J., Burgos M., Cabrera P., Small P.M., Enarson D.A. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. American Journal of Respiratory and Critical Care Medicine 2001, 163:717-720.
10. Chiang C.Y., Riley L.W. Exogenous reinfection in tuberculosis. Lancet Infectious Diseases 2005, 5:629-636.
11. Cohen T., Sommers B., Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect. Dis. 2003, 3:13-21.
12. Cohen T., Colijn C., Finklea B., Murray M. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. Journal of the Royal Society Interface 2007, 4:523-531.
13. Cohen T., Colijn C., Murray M. Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proceedings of the National Academy of Sciences 2008, 105:16302-16307.
14. Cohen T., Wilson D., Wallengren K., Samuel E.Y., Murray M. Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. Journal of Clinical Microbiology 2011, 49:385-388.
15. Colijn C., Cohen T., Murray M. Latent coinfection and the maintenance of strain diversity. Bulletin of Mathematical Biology 2009, 71:247-263.
16. Dickman K.R., Nabyonga L., Kateete D.P., Katabazi F.A., Asiimwe B.B., Mayanja H.K., Okwera A., Whalen C., Joloba M.L. Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda. BMC Infectious Diseases 2010, 10:349.
17. Dobler C.C., Crawford A.B.H., Jelfs P.J., Gilbert G.L., Marks G.B. Recurrence of tuberculosis in a low-incidence setting. European Respiratory Journal 2009, 33:160-167.
18. Dye C., Williams B.G. Criteria for the control of drug-resistant tuberculosis. Proceedings of the National Acadamy of Science of the United States of America 2000, 97:8180-8185.
19. de Jong B.C., Hill P.C., Aiken A., Awine T., Antonio M., Adetifa I.M., Jackson-Sillah D.J., Fox A., DeRiemer K., Gagneux S., Borgdorff M.W., McAdam K.P.W.J., Corrah T., Small P.M., Adegbola R.A. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia. Journal of Infectious Diseases 2008, 198:1037-1043.
20. Gagneux S., Long C.D., Small P.M., Van T., Schoolnik G.K., Bohannan B.J.M. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006, 312:1944-1946.
21. Garcia de Viedma D., Marin M., Hernangomez S., Diaz M., Serrano M.J.R., Alcala L., Bouza E. Tuberculosis recurrences-reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Archives of Internal Medicine 2002, 162:1873-1879.
22. Glynn J.R., Whiteley J., Bifani P.J., Kremer K., van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerging Infectious Diseases 2002, 8:843-849.
23. Gomes M.G.M., Franco A.O., Gomes M.C., Medley G.F. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proceedings of the Royal Society B 2004, 271:617-623.
24. Iannelli M., Martcheva M., Li X.-Z. Strain replacement in an epidemic model with super-infection and perfect vaccination. Mathematical Biosciences 2005, 195:23-46.
25. Iwamoto T., Yoshida S., Suzuki K., Wada T. Population structure analysis of the Mycobacterium tuberculosis beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrobial Agents and Chemotherapy 2008, 52:3805-3809.
26. Jacobs A.L. Infective dose in pulmonary tuberculosis. Tubercle 1941, 22:266-271.
27. Lambert M.L., Hasker E., van Deun A., Roberfroid D., Boelaert M., van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection?. Lancet Infectious Diseases 2003, 3:282-287.
28. Lipsitch M., Colijn C., Cohen T., Hanage W.P., Fraser C. No coexistence for free: neutral null models for multistrain pathogens. Epidemics 2009, 1:2-13.
29. Lopez B., Aguilar D., Orozco H., Burger M., Espitia C., Ritacco V., Barrera L., Kremer K., Hernandez-Pando R., Huygen K., van Soolingen D. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clinical and Experimental Immunology 2003, 133:30-37.
30. Luciani F., Sisson S.A., Jiang H., Francis A.R., Tanaka M.M. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. PNAS 2009, 106:14711-14715.
31. Lumb R., Ardian M., Waramori G., Syahrial H., Tjitra E., Maguire G.R., Anstey N.M., Kelly R.M. An alternative method for sputum storage and transport for Mycobacterium tuberculosis drug resistance surveys. International Journal of Tuberculosis and Lung Disease 2006, 10:172-177.
32. Mallard K., McNerney R., Crampin A.C., Houben R., Ndlovu R., Munthali L., Warren R.M., French N., Glynn J.R. Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. Journal of Clinical Microbiology 2010, 48:4512-4518.
33. Musser J.M., Amin A., Ramaswamy S. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics 2000, 155:7-16.
34. Niemann S., Richter E., Rusch-Gerdes S., Schlaak M., Greinert U. Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis. Emerging Infectious Diseases 2000, 6:548-551.
35. Niemann S., Diel R., Khechinashvili G., Gegia M., Mdivani N., Tang Y.W. Mycobacterium tuberculosis Beijing Lineage Favors the Spread of Multidrug-Resistant Tuberculosis in the Republic of Georgia. Journal of Clinical Microbiology 2010, 48:3544-3550.
36. Parwati I., van Crevel R., van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 2010, 10:103-111.
37. Richardson M., Carroll N.M., Engelke E., van der Spuy G.D., Salker F., Munch Z., Gie R.P., Warren R.M., Beyers N., van Helden P.D. Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting. Journal of Clinical Microbiology 2002, 40:2750-2754.
38. Shamputa I.C., Rigouts L., Eyongeta L.A., Aila N.A.E., van Deun A., Salim A.H., Willery E., Locht C., Supply P., Portaels F. Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients. Journal of Clinical Microbiology 2004, 42:5528-5536.
39. Shamputa I.C., Jugheli L., Sadradze N., Willery E., Portaels F., Supply P., Rigouts L. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Respiratory Research 2006, 7:99.
40. Shcherbakov D., Akbergenov R., Matt T., Sander P., Andersson D.I., Bottger E.C. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Molecular Microbiology 2010, 77:830-840.
41. Stavrum R., Mphahlele M., Ovreas K., Muthivhi T., Fourie P.B., Weyer K., Grewal H.M.S. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 Isolates. Journal Of Clinical Microbiology 2009, 47:1848-1856.
42. Strauss O.J., Warren R.M., Jordaan A., Streicher E.M., Hanekom M., Falmer A.A., Albert H., Trollip A., Hoosain E., van Helden P.D., Victor T.C. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. Journal of Clinical Microbiology 2008, 46:1514-1516.
43. Tanveer M., Hasan Z., Kanji A., Hussain R., Hasan R. Reduced TNF-α and IFN-γ responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009, 103:581-587.
44. Thwaites G., Caws M., Chau T.T.H., D'Sa A., Lan N.T.N., Huyen M.N.T., Gagneux S., Anh P.T.H., Tho D.Q., Torok E., Nhu N.T.Q., Duyen N.T.H., Duy P.M., Richenberg J., Simmons C., Hien T.T., Farrar J. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. Journal of Clinical Microbiology 2008, 46:1363-1368.
45. Tsolaki A.G., Gagneux S., Pym A.S., de la Salmoniere Y.-O.L.G., Kreiswirth B.N., Soolingen D.V., Small P.M. Genomic Deletions Classify the Beijing/W Strains as a Distinct Genetic Lineage of Mycobacterium tuberculosis. Journal of Clinical Microbiology 2005, 3185-3191.
46. van Crevel R., Nelwan R.H.H., de Lenne W., Veeraragu Y., van der Zanden A.G., Amin Z., van der Meer J.W.M., van Soolingen D. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerging Infectious Diseases 2001, 7:880-883.
47. van Rie A., Victor T.C., Richardson M., Johnson R., van der Spuy G.D., Murray E.J., Beyers N., van Pittius N.C.G., van Helden P.D., Warren R.M. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. American Journal of Respiratory and Critical Care Medicine 2005, 172:636-642.
48. Wang, J.Y., Hsu, H.L., Yu, M.C., Chiang, C.Y., Yu, F.L., Yu, C.J., Lee, L.N., Yang, P.C., the TAMI Group, in press. Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, riskfactors, and dominant strain. Clinical Microbiology and Infection, 17 doi:. http://10.1111/j.1469-0691.2010.03401.x.
49. Warren R.M., Victor T.C., Streicher E.M., Richardson M., Beyers N., van Pittius N.G., van Helden P.D. Patients with active tuberculosis often have different strains in the same sputum specimen. American Journal of Respiratory and Critical Care Medicine 2004, 169:610-614.
50. World Health Organization, 2009. Global Tuberculosis Control: A Short Update to the 2009 Report.
51. World Health Organization, 2010. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response.
52. Zeeman M.L. Extinction in competitive lotka-volterra systems. Proceedings of the American Mathematical Society 1995, 123:87-96.